Видео ютуба по тегу Parp Inhibition

How PARP inhibitors (PARPi) work
How PARP inhibitors (PARPi) work
Overcoming resistance to PARP inhibition in ovarian cancer
Overcoming resistance to PARP inhibition in ovarian cancer
An Overview of PARP Inhibitors in Ovarian Cancer
An Overview of PARP Inhibitors in Ovarian Cancer
Gynecologic Cancer Education: PARP Inhibitor Therapy
Gynecologic Cancer Education: PARP Inhibitor Therapy
Choosing the correct PARP inhibitor for prostate cancer
Choosing the correct PARP inhibitor for prostate cancer
Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer
Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer
PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer
PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer
Updates in PARP inhibition for ovarian cancer
Updates in PARP inhibition for ovarian cancer
Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute
Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute
PARP inhibitors for ovarian cancer
PARP inhibitors for ovarian cancer
PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat
PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat
PARP Inhibition in BRCA1/2+ or HRD- Ovarian Cancer
PARP Inhibition in BRCA1/2+ or HRD- Ovarian Cancer
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment
Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment
The benefits of adjuvant CDK4/6 and PARP inhibition in breast cancer
The benefits of adjuvant CDK4/6 and PARP inhibition in breast cancer
PARP Inhibitors for Prostate Cancer
PARP Inhibitors for Prostate Cancer
PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics
PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics
PARP Inhibitor Toxicity Management
PARP Inhibitor Toxicity Management
What’s New with PARP Inhibitors and Ovarian Cancer?
What’s New with PARP Inhibitors and Ovarian Cancer?